STAG2 and Patent ductus arteriosus: Our finding that RNAi-based silencing of STAG2 sensitizes PDA cells specifically to platinum-based therapies in vitro suggests that the increased therapeutic benefit seen in patients receiving adjuvant therapies could be further enhanced.